| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/29/2013 | US8362027 Iontophoretic preparation for treatment of breast cancer and/or mastitis |
| 01/29/2013 | US8362017 N-[5-chloro-2-(methyloxy)phenyl]-2-{[3-(1H-tetrazol-1-yl)phenyl]oxy}acetamide; antiproliferative agents; protein kinase inhibitors; drug screening |
| 01/24/2013 | US20130023528 Prolylhydroxylase inhibitors and methods of use |
| 01/24/2013 | US20130023527 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 01/24/2013 | US20130022629 Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof |
| 01/23/2013 | EP2548873A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 01/23/2013 | EP2547664A1 Morpholinylquinazolines |
| 01/23/2013 | EP2547663A1 A process for the preparation of highly pure ambrisentan |
| 01/23/2013 | EP2547662A1 Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists |
| 01/23/2013 | CN102892755A Therapeutic compounds |
| 01/23/2013 | CN102887862A Method for synthesizing erlotinib |
| 01/23/2013 | CN102887861A New crystal form of Ambrisentan and preparation method thereof |
| 01/23/2013 | CN102887860A Preparation method of 4-chloro-6-trifluoromethylpyrimidine type compound |
| 01/23/2013 | CN102887836A L-phenylglycine derivative and application thereof |
| 01/23/2013 | CN102276537B Preparation method of 2-cyan-5-amiopyrimidine |
| 01/22/2013 | US8357798 Process for preparing N-alkylated hydroxypyrimidinone compounds |
| 01/22/2013 | US8357694 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds |
| 01/22/2013 | US8357684 Thyazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase |
| 01/22/2013 | US8357679 Hexafluoroisopropanol derivatives |
| 01/22/2013 | CA2537812C C-met modulators and method of use |
| 01/17/2013 | WO2013010102A2 Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
| 01/17/2013 | WO2013006971A1 Sulfur-containing compounds as anti-proliferative agents |
| 01/17/2013 | WO2012135697A3 Novel rho kinase inhibitors and methods of use |
| 01/17/2013 | US20130018065 Processes for the preparation of key intermediate for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof |
| 01/17/2013 | US20130018054 New compounds |
| 01/17/2013 | US20130018044 New inhibitors of cyclophilins and uses thereof |
| 01/17/2013 | US20130018033 Raf inhibitor compounds and methods of use thereof |
| 01/17/2013 | US20130018026 Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
| 01/17/2013 | US20130017162 Cosmetic composition, cosmetic treatment method, kit, and compound |
| 01/16/2013 | EP2545039A1 A process for making voriconazole |
| 01/16/2013 | CN102884049A Heterocyclic amides as ROCK inhibitors |
| 01/16/2013 | CN102884048A Amino-heteroaryl derivatives as HCN blockers |
| 01/16/2013 | CN102883783A Treatment agent for decomposition of chemical substance which comprises persulfuric acid salt and silver complex, and method for decomposition of chemical substance using same |
| 01/16/2013 | CN102883605A Co-crystals of pyrimethanil or cyprodinil |
| 01/16/2013 | CN102875481A 4-[2-(substituted benzylidene) hydrazino]-5, 6, 7-trialkoxy quinazoline compound and preparation method and application |
| 01/16/2013 | CN102875480A Quinazolinone vasoinhibitors, and preparation method and medical application thereof |
| 01/16/2013 | CN102875479A Quinazoline diketone derivative and preparation method, drug compound and application thereof |
| 01/16/2013 | CN102875478A Amine salts of a crth2 antagonist |
| 01/16/2013 | CN102872018A Tyrosine kinase irreversible inhibitor and preparation method and applications thereof |
| 01/16/2013 | CN101993419B Preparation method of 4-[(5-bromo-4,6-dichloro-2-pyrimidinyl)amino] cyanobenzene |
| 01/16/2013 | CN101921236B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 01/16/2013 | CN101899011B Dithiocarbamates compound, preparation method and application thereof |
| 01/15/2013 | US8354530 Process for the synthesis of rosuvastatin calcium |
| 01/15/2013 | US8354524 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids |
| 01/15/2013 | US8354421 HIV reverse transcriptase inhibitors |
| 01/15/2013 | US8354420 Aminopyrimidine derivatives as LRRK2 inhibitors |
| 01/15/2013 | US8354418 Thiazolyl-dihydro-quinazolines |
| 01/15/2013 | US8354414 Substituted bicyclic pyrimidines |
| 01/15/2013 | US8354407 2-anilino-4-(heterocyclic)amino-pyrimidines |
| 01/15/2013 | CA2572971C Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 01/10/2013 | WO2013005157A1 Sulfone derivatives and their use as pkm2 modulators for the treatment of cancer |
| 01/10/2013 | WO2013004995A1 Pyrimidinone compounds and their use |
| 01/10/2013 | WO2012085665A3 Novel processes for preparing triazolo[4,5-d]pyrimidine derivatives and intermediates thereof |
| 01/10/2013 | US20130012704 Compounds and compositions as protein kinase inhibitors |
| 01/10/2013 | US20130012530 New Positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/10/2013 | US20130012528 Novel derivatives of erlotinib |
| 01/10/2013 | US20130012506 Anti-infective pyrido (1,2-a) pyrimidines |
| 01/10/2013 | US20130012491 Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists |
| 01/10/2013 | US20130012490 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 01/09/2013 | EP2542536A1 Morpholino substituted urea derivatives as mtor inhibitors |
| 01/09/2013 | EP2542528A1 Heterocyclic amides as rock inhibitors |
| 01/09/2013 | CN102863395A Novel method for synthesizing Erlotinib |
| 01/09/2013 | CN102863394A Novel method for synthesizing Gefitinib |
| 01/09/2013 | CN102863345A Amino propylene glycol derivative, preparation method of amino propylene glycol derivative, medicine composition of amino propylene glycol derivative and application of amino propylene glycol derivative |
| 01/09/2013 | CN102093286B Acrylic acid endothelin receptor antagonist as well as preparation method and application thereof |
| 01/09/2013 | CN102079725B Method for preparing 2-chloropyrimidine |
| 01/08/2013 | US8350029 Process for the preparation of gefitinib |
| 01/08/2013 | US8349860 Inhibitors of syk and JAK protein kinases |
| 01/08/2013 | US8349858 Polycyclic guanine derivatives and use thereof |
| 01/08/2013 | US8349857 Quinazoline derivatives having tyrosine kinase inhibitory activity |
| 01/08/2013 | US8349853 Detection defect in gene expression of hedgehog gene; diagnosis of cancer |
| 01/08/2013 | US8349843 Carboxylic acid derivatives, their preparation and use |
| 01/08/2013 | US8349833 Compounds, compositions and methods useful for cholesterol mobilisation |
| 01/08/2013 | CA2695460C Phenobarbital derivatives useful in immunoassay |
| 01/08/2013 | CA2642665C Anti-cancer pharmaceutical composition |
| 01/08/2013 | CA2557372C Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
| 01/08/2013 | CA2447671C Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 01/03/2013 | WO2013003386A1 3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl (2,3,4,5,6-pentahydroxyhexyl) amino) ethoxy) phenyl) butyl) carbamimidoyl) pyrazine-2-carboxamide |
| 01/03/2013 | WO2013002364A1 Crystals of glycine derivative and pharmaceutical use thereof |
| 01/03/2013 | WO2012151141A3 A facile preparation of 4-substituted quinazolines and related heterocycles |
| 01/03/2013 | WO2012147091A3 Process for rilpivirine |
| 01/03/2013 | US20130005972 Application of Staudinger Ligation in PET Imaging |
| 01/03/2013 | US20130005964 Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 01/03/2013 | US20130005727 Quinazoline derivatives |
| 01/03/2013 | US20130005687 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
| 01/03/2013 | US20130005577 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides |
| 01/03/2013 | DE10114189B4 Verfahren zur Gewinnung von Wertstoffen aus Organismen durch Beeinflussung/Beeinträchtigung der zelleigenen Transportsysteme für diese Wertstoffe bzw. durch Verwendung von Produktionsstämmen, denen besagte Transportsysteme fehlen Process for the recovery of valuable materials from organisms by affecting / impairment of cell-specific transport systems for these valuable materials or by the use of production strains, which said transport systems are missing |
| 01/03/2013 | CA2838251A1 3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl) carbamimidoyl)pyrazine-2-carboxamide |
| 01/03/2013 | CA2837453A1 Crystals of glycine derivative and pharmaceutical use thereof |
| 01/02/2013 | EP2540706A2 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates |
| 01/02/2013 | EP2540705A2 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates |
| 01/02/2013 | EP2539323A1 Compounds as bradykinin b1 antagonists |
| 01/02/2013 | CN1995022B Process for the synthesis of nucleoside analogues |
| 01/02/2013 | CN1919846B Novel oriented synthesis method of voriconazole, medicinal salt and intermediate thereof |
| 01/02/2013 | CN102858791A Process for producing flurocytidine derivatives |
| 01/02/2013 | CN102858754A RAF inhibitor compounds and methods of use thereof |
| 01/02/2013 | CN102858753A Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase |
| 01/02/2013 | CN102858342A Arylvinylazacycloalkane compounds for constipation |
| 01/02/2013 | CN102850321A Aroxylpyrimidine formamide or aroxylpyridine formamide compound and its preparation method, pharmaceutical composition, and application |
| 01/02/2013 | CN102850280A 6,7-dialkyloxy-4-substituted phenylamino quinazoline compounds and preparation methods |